Real-World Retreatment of Sofosbuvir/Ledipasvir (SOF/LDV) Failures In Hepatitis C Virus Genotype 1 infection

被引：0
|
作者：
Pearlman, Brian [1 ,2 ]
Hinds, Andrew [1 ]
Perrys, Michael [2 ]
机构：
[1] Atlanta Med Ctr, Ctr Hepatitis C, Atlanta, GA USA
[2] Med Coll Georgia, Internal Med, Augusta, GA 30912 USA
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
948
引用
收藏
页码：478A / 478A
页数：1
相关论文
共 50 条
  • [11] REACTIVATION OF HEPATITIS B VIRUS AMONG PATIENTS TREATED WITH LEDIPASVIR-SOFOSBUVIR (LDV/SOF) FOR HEPATITIS C VIRUS INFECTION IN A COMMUNITY BASED SETTING
    Yanny, Beshoy
    Sahota, Amandeep
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1059 - S1059
  • [12] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Toshifumi Tada
    Takashi Kumada
    Hiroaki Okushin
    Joji Tani
    Koichi Takaguchi
    Akemi Tsutsui
    Hidenori Toyoda
    Satoshi Yasuda
    Kazufumi Dohmen
    Atsushi Hiraoka
    Kojiro Michitaka
    Kazuhiro Nouso
    Kazuya Kariyama
    Soo Ryang Kim
    Soo Ki Kim
    Shinichi Fujioka
    Shigeru Mikami
    Yuto Watanabe
    Tsutomu Tamai
    Masanori Atsukawa
    Norio Itokawa
    Hironori Tanaka
    Kunihiko Tsuji
    Toru Ishikawa
    Michitaka Imai
    Ei Itobayashi
    Hiroshi Shibata
    Noritomo Shimada
    [J]. Infectious Diseases and Therapy, 2021, 10 : 269 - 280
  • [13] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Tada, Toshifumi
    Kumada, Takashi
    Okushin, Hiroaki
    Tani, Joji
    Takaguchi, Koichi
    Tsutsui, Akemi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Dohmen, Kazufumi
    Hiraoka, Atsushi
    Michitaka, Kojiro
    Nouso, Kazuhiro
    Kariyama, Kazuya
    Kim, Soo Ryang
    Kim, Soo Ki
    Fujioka, Shinichi
    Mikami, Shigeru
    Watanabe, Yuto
    Tamai, Tsutomu
    Atsukawa, Masanori
    Itokawa, Norio
    Tanaka, Hironori
    Tsuji, Kunihiko
    Ishikawa, Toru
    Imai, Michitaka
    Itobayashi, Ei
    Shibata, Hiroshi
    Shimada, Noritomo
    [J]. INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 269 - 280
  • [14] Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/Sof) in Treatment-Experienced Cirrhotic Genotype 1 Patients With Chronic Hepatitis C (CHC): A Comparative Analysis of Gilead Sponsored Trials With 4 Real-World Cohorts (RWC)
    Flamm, Steven
    Modi, Apurva A.
    Pungpapong, Surakit
    Leise, Michael D.
    Aqel, Bashar
    Llewellyn, Joseph
    Williams, Laurie
    Natha, Macky
    Brainard, Diana
    Kreter, Bruce
    Kohli, Anita
    Wyles, David L.
    Lee, Yoori
    Reddy, K. R.
    Curry, Michael
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S1095 - S1095
  • [15] LEDIPASVIR (LDV)/SOFOSBUVIR (SOF) TREATMENT OF HEPATITIS C VIRUS (HCV) IS ASSOCIATED WITH REDUCTION OF SERUM APOLIPOPROTEIN LEVELS
    Younossi, Z.
    Elsheikh, E.
    Stepanova, M.
    Gerber, L.
    Nader, F.
    Brainard, D.
    McHutchinson, J. G.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S599 - S599
  • [16] REALWORLD EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR (LDV/SOF) IN TREATMENT-EXPERIENCED CIRRHOTIC GENOTYPE 1 PATIENTS WITH CHRONIC HEPATITIS C: A COMPARATIVE ANALYSIS OF GILEAD SPONSORED TRIALS WITH 4 REAL-WORLD COHORTS
    Curry, M.
    Modi, A. A.
    Pungpapong, S.
    Leise, M.
    Aqel, B.
    Llewellyn, J.
    Williams, L. A.
    Natha, M.
    Brainard, D. M.
    Kreter, B.
    Kholi, A.
    Wyles, D.
    Lee, Y.
    Reddy, R.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S797 - S797
  • [17] Effectiveness and safety of ledipasvir/ sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan
    Chiu, Hung-Chih
    Chiu, Yen-Cheng
    Yang, Er-Hsiang
    Chang, Ting-Tsung
    Chien, Shih-Chieh
    Wu, I-Chin
    Wu, Chun-Hsien
    Cheng, Pin-Nan
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (03) : 983 - 990
  • [18] Ledipasvir and sofosbuvir:Interferon free therapy for hepatitis C virus genotype 1 infection
    Yasir Waheed
    [J]. World Journal of Virology, 2015, (01) : 33 - 35
  • [19] SIX WEEKS OF SOFOSBUVIR/ LEDIPASVIR (SOF/LDV) ARE SUFFICIENT TO TREAT ACUTE HEPATITIS C VIRUS GENOTYPE 1 MONOINFECTION: THE HEPNET ACUTE HCV IV STUDY
    Deterding, K.
    Spinner, C.
    Schott, E.
    Welzel, T.
    Gerken, G.
    Klinker, H.
    Spengler, U.
    Wiegand, J.
    zur Wiesch, J. Schulze
    Pathil, A.
    Cornberg, M.
    Umgelter, A.
    Zoellner, C.
    Zeuzem, S.
    von der Leyen, H.
    von Witzendorff, D.
    Manns, M. P.
    Wedemeyer, H.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S211 - S211
  • [20] Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure
    Kalal, Chetan
    Shukla, Akash
    Mohanka, Ravi
    Vora, Mihir
    Patel, Priyesh
    Shah, Samir
    [J]. HEPATOLOGY, 2018, 67 (05) : 2049 - 2050
12345